ClinicalTrials.gg
RecruitingNCT07565454Updated Jun 10, 2026

Evaluation of Hepato-Pancreato-Biliary

An observational study in Gastro-Intestinal Disorder, sponsored by Methodist Health System. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-06-10.

Sponsored by Methodist Health System · Observational

From the registry’s dates

  • Started Apr 2021; still recruiting 5 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
100
Sex
All
01

Study summary

Some reports cite over 80% of surgery residency graduates are seeking additional training to improve on their experiences to be ready for practice. The Fellowship Council created several fellowship tracts including HPB (Hepato-Pancreato-Biliary),Advanced GI (gastrointestinal) and Minimally Invasive surgery to address this issue, and bridge the gap in training between residency and real life practice in those that seek a practice in HPB or complex GI surgery, respectively. By the end of fellowship, the core goal is to make the graduating fellows ready for independent practice in HPB or complex GI surgery cases.

Read the detailed description

The main aim of this study is to evaluate and compare the efficacy of our training within the Fellowship Council curriculums. In addition, we aim to examine the job market and perceptions regarding training for graduates of the Fellowship Council's fellowships domains.

02

Conditions studied

  • Gastro-Intestinal Disorder
03

In context

Digestive System Diseases

406 studies on the registry are indexed under Digestive System Diseases; 79 are open to participants now.

This study's planned enrollment of 100 is below the median of 400 across 105 observational studies indexed under Digestive System Diseases.

Browse Digestive System Diseases studies →

Lead sponsor

Methodist Health System is the lead sponsor of 170 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

This study will follow a general survey design intended to create various surveys to help improve fellowship curriculum to better serve future HPB and Advance GI Surgeons.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Current, and past fellows of Fellowship Council(FC )sponsored fellowship including Americas Hepato-Pancreato-Biliary Association(AHPBA)-accredited HPB and Advanced GI surgery fellowship.
  2. Current senior surgeons involved in Fellowship Council(FC) fellowship training.

Exclusion criteria

Exclusion Criteria:

Fellows who choose not to respond to the survey

05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Present general surgery residents

    compare current fellowship structure to better serve future surgeons.

    Behavioral: Evaluate and compare the efficacy of our training within the Fellowship Council curriculums

Interventions

  • BehavioralEvaluate and compare the efficacy of our training within the Fellowship Council curriculums

    The product of our fellowship must be constantly evaluated to make sure the goal, which is to produce competent, independent surgeons capable of treating Hepato-Pancreato-Biliary(HPB) and complex Gastrointestinal(GI) surgery disease processes is met.

06

What researchers measure

Primary outcomes

  1. Efficacy of HPB and Advanced GI surgery fellowship curriculums

    Survey questions will either examine the readiness of our trainees coming into the fellowship, our current fellowship curriculum, and/or the outcome of our fellows once they complete and graduate from their advanced training.

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All information will be blinded in compliance with good clinical practice. The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of Survey or research information. Only de-identified surveyor information will be shared in relevant research mediums. These mediums may range from national, regional, local and/or international sites. In addition, study data and findings may be submitted for presentation at local and national conferences. As study protocol is intended to cover multiple surveys we are unaware where these publications will be used at this time. Publication reference will be added ad hoc to maintain in records.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2021 (actual). Primary completion is estimated for Jan 2027, 69 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2026
First posted
May 4, 2026
StartActual
Apr 1, 2021
Primary completionEst.
Jan 2027
CompletionEst.
Jan 2028
Last update
Jun 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07565454
Responsible party
Sponsor
First posted
May 4, 2026
Start date
Apr 1, 2021
Primary completion
Jan 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Jun 10, 2026

Study contacts

Crystee Cooper, DHEd
Contact
ClinicalResearch@mhd.com
214-947-1280
Kavya Mankulangara
Contact
ClinicalResearch@mhd.com
214-947-4604
Rohan Jeyarajah, MD
principal investigator · Methodist Health System

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion